Skip to main content
. 2014 Feb 3;15(2):R30. doi: 10.1186/gb-2014-15-2-r30

Table 2.

Infinium sensitivity and specificity

 
Sensitivity
  Deletion Loss Gain Amplification
Chondrosarcoma
0.83
0.91
0.89
0.69
GBM
0.97
0.85
0.87
0.75
Bladder cancer
0.62
0.81
0.79
0.67
Prostate cancer 0.6 0.81 0.85 0.63

The sensitivity and specificity of CNAs identified between SNP array and Infinium methylation arrays for four tumor types across a range of alteration types.